Funded by the NIH HEAL Initiative®
This project will develop models to predict individual patient’s risk for relapse (or dropout from treatment) when treated with medications for OUD including methadone, buprenorphine, or extended-release depot naltrexone.
Principal Investigator(s)
Sean Luo, MD, Ph.D.
1051 Riverside Drive, Unit 66
New York, NY 10033
United States
Daniel J. Feaster, Ph.D.
1120 NW 14th Street, Suite 1059
Miami, FL 33136
United States